French Pharma Stock News

TotalEnergies (ENXTPA:TTE) plans to bring the new Acacia-5 oil discovery on Angola's Block 17 into production within three months. The group intends to use existing FPSO facilities on Block 17 to accelerate Acacia-5 deployment instead of building new infrastructure. TotalEnergies has expanded its Angolan portfolio by acquiring operated interests in exploration Blocks 17/25 and 32/21 in the Lower Congo Basin. The rapid Acacia-5 start up and new Angola blocks matter, but investors should weigh...

Aeroports de Paris (ENXTPA:ADP) has drawn attention after its recent trading left the shares at €108.90, with returns mixed across short and longer periods and a modest gain over the past 3 years. Recent trading reflects that pattern, with Aeroports de Paris posting a 1-day share price return of 0.55% and a 30-day share price return that is down 4.72%, while the 1-year total shareholder return has slipped 0.90% and the 5-year total shareholder return is up 20.14%. Compare Aeroports de Paris...

Soitec (ENXTPA:SOI) raised its earnings guidance for the second quarter of fiscal 2027, telling investors it now targets about 50% year-on-year revenue growth instead of the previously flagged more than 30%. Soitec shares trade at €141.15 after a 3.37% one-day share price return and a 10.02% seven-day share price return, adding to a very large year-to-date share price gain of about 4.7x that appears linked to the upgraded revenue outlook. However, the three-year and five-year total...

Roche Bobois stock has been under pressure, with the share price down about 20% over the past three months and roughly 8% over the past month. The latest half year report did not change that mood. H1 2026 revenue came in at €187.8 million and net income at €3.3 million, keeping the trailing net profit margin around 2%, below last year’s 3.2% level. The short term story is a luxury furniture group experiencing thinner profitability. The longer term question is whether a business priced on a...

Accor expansion in Egypt puts growth plans in focus Accor (ENXTPA:AC) is in the spotlight after outlining plans to add around 25,000 hotel rooms in Egypt over the next three years and explore a specialised hospitality academy. Management discussed these expansion plans with Egyptian Prime Minister Mostafa Madbouly, alongside government support for a broader set of Accor brands and refurbishment of existing luxury properties with local investor partnerships. These Egypt plans arrive as Accor’s...

Airbus stock presents a tricky mix right now, with a strong 5 year gain already on the table while several valuation checks still flag the shares as cheap relative to an intrinsic value estimate and to market multiples. The share price has returned 92.3% over 5 years, which means anyone looking at Airbus today is assessing a company that has already delivered a sizeable long term gain. Fresh aircraft orders in both passenger and freighter markets may support expectations for future cash...

Sanofi (ENXTPA:SAN) is expanding its commercial leadership for the Nuvaxovid COVID-19 vaccine targeting the new XFG variant for the 2026-2027 season. The rollout focuses on key markets including the U.S., European Union, and Japan, with further launches planned in Germany, Canada, and additional countries. The Nuvaxovid agreement structure broadens commercial reach for the vaccine within Sanofi's wider vaccines portfolio and global distribution network. The expanded Nuvaxovid XFG rollout...

Vetoquinol stock has quietly added double digit gains over the past three months, yet the latest move hinges on one key idea: margin credibility. H1 2026 revenue landed at €259.3 million, broadly steady, while net income reached €30.5 million. That keeps trailing net profit margin close to 12%, a rare pocket of stability in animal health where input costs can easily squeeze profitability. The market is reacting to that resilience as much as the headline earnings line, rewarding a business...

Sogeclair entered this earnings season with a reputation as a quietly cheap aerospace and defense stock. The price is still around €32.4 and the 30 day return is down about 4%, even as trailing 12 month earnings from continuing operations sit near €7.977 million and the stock trades on a reported P/E of 14.6x that is well below sector averages. The headline from this half year release is not rapid revenue growth but a profit picture that remains intact, which keeps the valuation gap in sharp...

Orange has completed a €4.1b multi tranche euro bond issue across four maturities from 2029 to 2038, plus a separate €744.69 million fixed income deal, all at fixed coupons between 3.625% and 4.5%. An order book of €16b against €4.1b issued indicates strong credit market appetite for Orange’s balance sheet and its "Trust the future" plan. We will examine how Orange's investment narrative is influenced by this oversubscribed multi tranche bond issuance and the additional financing. Capture...

Bureau Veritas (ENXTPA:BVI) has raised €700 million through a 4.125% bond maturing in 2034, refinancing debt coming due in 2026 and 2027 after attracting strong demand from fixed income investors. Investors have rewarded Bureau Veritas with a 9.47% 90 day share price return and an 8.79% 1 year total shareholder return, although momentum has cooled slightly over the past month as the 30 day share price return slipped just under flat territory. Scan how Bureau Veritas compares with other...

Sopra Steria Group (ENXTPA:SOP) just expanded its cybersecurity offering through a partnership with VMRay, a European malware and phishing specialist, raising fresh questions about how this deeper cyber focus might influence the stock’s appeal. The VMRay tie-up comes after a choppy stretch for Sopra Steria Group’s stock. The 7-day share price return is down 10.62% and the 30-day share price return is down 15.19%, while the 90-day share price return is up 7.29% and the 1-year total shareholder...

French bond yields near 4.45%, a 25% jump in 2026 debt-servicing costs to €65bn, and weaker growth expectations have pushed cash and short-duration products into the spotlight. Investors worried about sovereign risk and funding costs are rethinking where they park euros. This article walks through 3 Eurozone-listed stocks exposed to these pressures, highlighting where current conditions might help or hurt future cash-management opportunities. The three stocks below are only a starter set, and...

Eramet (ENXTPA:ERA) has restarted mining at PT Weda Bay Nickel in Indonesia after a four month halt, a move that directly affects nickel ore volumes and future external sales guidance. For context, ERAMET’s share price has retreated over the year despite today’s €45.68 level. The 90-day share price return is down 17.17% and the year-to-date share move is down 25.84%, while the 1-year total shareholder return has fallen a milder 1.30%. Scan how ERAMET compares to other producers exposed to...

European equities have faced recent pressures due to rising energy prices and elevated bond yields, driven by geopolitical tensions and inflation concerns. In this environment, investors may find opportunities in stocks trading below their estimated intrinsic values, as these can offer potential for growth when market conditions stabilize.

Legrand (ENXTPA:LR) drew investor attention after its recent share price moved to €139.50, with performance mixed over the past month but positive over the past 3 months and year to date. In the short term, Legrand’s 1-week and 3-month share price returns point to building momentum. Over 1-year and multi-year periods, the total shareholder returns suggest that investors who stayed invested have seen meaningfully stronger overall outcomes once dividends are included. Scan how Legrand compares...

Rubis reported half year 2026 results, with sales of €4,067.52 million, net income of €191.41 million and basic EPS from continuing operations of €1.85, all higher than the figures a year earlier. The alignment of rising sales, stronger net income and unchanged basic and diluted EPS indicates operating performance that kept the share count stable while improving profitability per share. We will now assess how Rubis' higher half year net income could influence the existing investment...

It looks like SPIE SA ( EPA:SPIE ) is about to go ex-dividend in the next 3 days. The ex-dividend date is commonly two...

We feel now is a pretty good time to analyse Nanobiotix S.A.'s ( EPA:NANO ) business as it appears the company may be...

OVHcloud US has launched Public VCF-as-a-Service in the U.S., offering a fully managed VMware Cloud Foundation environment with bundled licensing, infrastructure, and platform management for customers that want to modernize VMware workloads without large migrations. The service targets small and mid-sized businesses and managed service providers, which could deepen OVH Groupe’s reach into VMware-heavy clients that prefer subscription-based, outsourced infrastructure rather than running their...

Ipsos reported that, in early September 2026, long-serving executive Trinh Tu became CEO for the UK & Ireland and joined the Executive Management Committee, following a three decade career at the firm that has spanned research, public affairs leadership and business growth roles. Her mix of commercial growth experience, public sector exposure and governance roles, including vice chairing UK for UNHCR, gives Ipsos an operator who understands both large institutional clients and the cost...

Séché Environnement stock has been soft in recent weeks, with the share price slipping about 8% over 3 months to €77.3. Yet the latest half year numbers tell a more complex story. Revenue in H1 2026 came in at €652.1m while net income reached €12.2m, leaving the trailing net margin at a thin 1.4%. The real headline is the squeeze on profitability. A richer P/E multiple of 33.8x now rests on a business where earnings from continuing operations over the last twelve months total €28.0m and...

Neurones shares have drifted over the past month, yet today’s earnings dropped a quiet challenge to that caution. The stock closed at €36.25 after a soft 30 day move, while the business posted H1 2026 revenue of €454.8m and trailing 12 month earnings from continuing operations of €66.3m. The real flashpoint is valuation. A P/E of 15.7x and a discounted cash flow estimate of €41.09 create a gap that traders appear to be testing against their nerves rather than the numbers. Love that Neurones...

Interparfums stock closed at €27.70 after a choppy week, barely moved over seven days but still ahead over one and three months. The mood today hinges on one thing: profit power. H1 2026 basic earnings per share of €0.78 and net income of €65.46m sit against a trailing P/E of 20.5x, with the valuation already richer than the broader European personal products group. Traders are reacting less to the headline revenue line and more to a market that had been pricing in solid profitability, now...